Skip to content
Brand AI

Taysha Gene Therapies

Request correction

Corporate brand

UnclaimedRead 4× by AI crawlers

Taysha Gene Therapies is a company focused on gene therapy programs for central nervous system diseases.

Last updated September 1, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Taysha Gene Therapies aims to eradicate monogenic CNS disease and focuses on gene therapy programs with the potential to transform care for patients with central nervous system diseases, starting with Rett syndrome.

History

Taysha Gene Therapies states that it wants to do more than just treat monogenic CNS disease; it wants to eradicate it. Its science focuses on gene therapy programs with the potential to transform care for patients with central nervous system (CNS) diseases, starting with Rett syndrome.

Recent events

  • Reported

    Taysha Gene Therapies reports full-year 2020 results[5]

    Taysha Gene Therapies reported financial results for the full year ended December 31, 2020, including a net loss of $60.0 million.

Read more

Sources5 sources

  1. 1Taysha GTxtayshagtx.com
  2. 2About Us | Taysha GTxtayshagtx.com
  3. 3Pipeline | Taysha GTxtayshagtx.com
  4. 4Our Science | Taysha GTxtayshagtx.com
  5. 5Taysha Gene Therapies公布2020全年业绩biospace.com

Cite this profile: Cite the canonical profile. /brand-wiki/taysha-gene-therapies · Editorial policy · How profiles are compiled